Detection of RACK1 and CTNNBL1‑Induced Activation of Mouse Splenocytes Using an Immunoprecipitation‑Based Technique

Total Page:16

File Type:pdf, Size:1020Kb

Detection of RACK1 and CTNNBL1‑Induced Activation of Mouse Splenocytes Using an Immunoprecipitation‑Based Technique 7056 MOLECULAR MEDICINE REPORTS 16: 7056-7063, 2017 Detection of RACK1 and CTNNBL1‑induced activation of mouse splenocytes using an immunoprecipitation‑based technique BOHAN DONG1,2, GUANGLI DAI3, LEI XU1,2 and DAMIN SHI1 1Department of Biochemistry; 2Anhui Key Laboratory of Active Biological Macro‑Molecules, Wannan Medical College, Wuhu, Anhui 241002; 3Department of Gynecology and Obstetrics, Traditional Chinese Medical Hospital of Wuhu, Wuhu, Anhui 241000, P.R. China Received November 17, 2016; Accepted July 4, 2017 DOI: 10.3892/mmr.2017.7485 Abstract. Tumor cell lysates (TCLs) have been reported to or tumor-associated proteins and peptides (2). Tumor cell induce antitumor immunity; however, it remains unclear which lysates (TCLs) have been reported to induce antitumor immu- elements serve a role in this process. The present study identi- nity, since all antigens and signal transduction factors that are fied 768 proteins that were upregulated in TCL prepared from present in tumor cells exist in the TCL (3,4); thus, they may Lewis lung cancer cells compared with the lysate from type II have potential to be used in antitumor vaccines. In a dendritic alveolar epithelial cells. Among the proteins that were upregu- cell (DC)‑based antitumor study, lung cancer TCL was used lated in TCL, receptor for activated C kinase 1 (RACK1) and to activate mouse DCs in vitro; subsequently, the activated catenin β‑like 1 (CTNNBL1) are closely associated with cell DCs were transfused back into the mice to treat the tumor (5). proliferation and the inhibition of apoptosis. To determine the In addition, our previous study combined Lewis lung cancer role of these proteins in TCL, a protein extraction method was TCL with heat shock protein 65 to activate immunocytes in designed, which was based on immunoprecipitation. Using mice; the results demonstrated that the activated immunocytes this method, RACK1 and CTNNBL1 were extracted, whereas induced anti‑lung cancer immunity in vivo (6). Although TCLs the other proteins within the TCL were not affected. The have been used in antitumor immunotherapy, the key proteins modified TCL exhibited a stronger ability to induce spleno- involved in antitumor immunity remain unknown. Receptor cyte apoptosis, whereas the ability to promote cell activation for activated C kinase 1 (RACK1) is expressed in numerous was reduced. These findings suggested that the TCL depends tumor types, including lung cancer, colorectal cancer and on RACK1 and CTNNBL1 to activate mouse immunocytes, hepatocellular carcinoma (7). This factor is able to activate including monocytes and B lymphocytes, and inhibit apop- the Sonic hedgehog signaling pathway, which promotes tumor tosis. Therefore, the present study may provide information cell proliferation and inhibits apoptosis (8). Similarly, catenin regarding the composition of TCLs and their positive regula- β‑like 1 (CTNNBL1) is a protein that has been detected in tory effect on immunocytes. colorectal cancer, osteosarcoma and B lymphocytes (9-12). Although the function of this protein has yet to be determined, Introduction it has been identified as a putative regulator of the canonical Wnt signaling pathway using RNA interference technology, Tumor incidence is associated with impaired antitumor immu- where it acts upstream of, or in parallel to β-catenin, particu- nity in the patients. Effectively stimulating the immune system larly in colorectal cancer cell proliferation (9). RACK1 and to kill tumor cells is a critical factor for the success or failure CTNNBL1 are expressed in numerous tumor cell types to of antitumor immunotherapy (1). Efforts have been made to transduce the Sonic hedgehog cell proliferation signaling construct antitumor vaccines, aiming to induce antitumor pathway; therefore, it is hypothesized that these proteins immunity using tumor cells, genes that express tumor antigens must also exist in TCLs. In the present study, RACK1 and CTNNBL1 were detected in TCL prepared from Lewis lung cancer cells, and their roles in the activation of mouse spleno- cytes were determined. Correspondence to: Dr Bohan Dong, Department of Biochemistry, Wannan Medical College, 22 Wenchang West Road, Wuhu, Materials and methods Anhui 241002, P.R. China E-mail: [email protected] Animals and cell lines. Female C57BL/6 mice (n=9; age, 6‑8 weeks; weight, 18‑22 g) were purchased from Anhui Key words: tumor cell lysate, vaccine, mouse splenocytes, Medical University Laboratory Animal Center (Hefei, immunocyte, apoptosis, lung cancer, receptor for activated C China) and were maintained in microisolator cages under kinase 1, catenin β‑like 1 pathogen‑free conditions, at a temperature of 20‑26˚C under a 12‑h light/dark cycle. Food and water was autoclaved before feeding and provided ad libitum. The mice were evenly DONG et al: RACK1 AND CTNNBL1 INDUCE ACTIVATION OF MOUSE SPLENOCYTES 7057 divided into 3 groups; a PBS group, whole TCL group and 12,000 x g overnight at 4˚C. Acidified with 50% CF3COOH, TCL RACK1‑/CTNNBL1‑group. Experimental manipulation the peptides were separated using linear gradient elution; the of the mice was undertaken in accordance with the National mobile phases were comprised as follows: Mobile phase A, Institutes of Health Guide for the Care and Use of Laboratory 5% ACN and 0.1% formic acid (FA); mobile phase B, 80% Animals (https://www.ncbi.nlm.nih.gov/books/NBK54050), ACN and 0.1% FA. The gradient was increased from 5 to 90% with the approval of the Scientific Investigation Board of mobile phase B in 50 min at a flow rate of 300 nl/min. The Science and Technology of Anhui Province and the animal tandem mass spectrometry (MS/MS) analysis was performed experiments of the present study were also approved by the using a Q Exative system (Thermo Fisher Scientific, Inc.) Ethics Committee of Wannan Medical College. The mouse in Information‑Dependent Mode. Briefly, MS spectra were Lewis lung cancer cell line was purchased from Wuhan acquired across the mass range of 350‑1800 m/z in high Boster Biological Technology, Ltd. (Wuhan, China). The cells resolution mode (>70,000 full width at half maximum) using were cultured in high‑glucose Dulbecco's modified Eagle's a 40 msec accumulation time per spectrum. A maximum of medium (Hyclone; GE Healthcare Life Sciences, Logan, UT, 20 precursors per cycle were chosen for fragmentation from USA) supplemented with 10% fetal calf serum (FCS; Gibco; each MS spectrum with 60 msec minimum accumulation Thermo Fisher Scientific, Inc., Waltham, MA, USA), 100 U/ml time for each precursor and dynamic exclusion for 20 sec. penicillin and 100 µg/ml streptomycin (Sigma‑Aldrich; Merck Tandem mass spectra were recorded in high sensitivity KGaA, Darmstadt, Germany). The present study was approved mode (resolution>17,500) with rolling collision energy on by the Ethics Committee of Wannan Medical College (Wuhu, and iTRAQ reagent collision energy adjustment on. For China). protein identification, the MS/MS spectra were processed using ProteinPilot software version 5.0 (Sciex, Framingham, Preparation of TCL. To prepare the TCL, cultured Lewis cells MA, USA). Differentially abundant proteins were examined were lysed using a freeze‑thaw cycle in PBS solution between using QuickGO (https://www.ebi.ac.uk/QuickGO/) for Gene ‑70˚C and 37˚C. After five cycles, the prepared TCL was Ontology annotation and enrichment analysis. stored at ‑70˚C until further use. The TCL was observed under a microscope (Olympus Corporation, Tokyo, Japan) using Reverse transcription‑quantitative polymerase chain reaction trypan blue staining (Sigma‑Aldrich; Merck KGaA) to ensure (RT‑qPCR). Total RNA was extracted from mouse Lewis lung all of the cells were lysed. cancer cell whole TCL and reverse transcribed into cDNA using an RNAprep pure kit (Tiangen Biotech Co. Ltd., Beijing, Preparation of mouse type II alveolar epithelial cell lysate. China) and FastQuant RT kit (with gDNase; Tiangen Biotech To prepare the lysate, cultured type II alveolar epithelial cells Co. Ltd.), respectively. Oligo dT mixed with total RNA was were lysed using a freeze‑thaw cycle in PBS solution between and placed in a warm bath at 70˚C for10 min, and then into ‑70˚C and 37˚C. After five cycles, the prepared lysate was ice‑water mixture. dNTP\RTase\Rnase free H2O was added stored at ‑70˚C until further use. The lysate was observed to prepare the reverse transcription reaction system. The under a microscope (Olympus Corporation, Tokyo, Japan) system was warmed at 42˚C for 1 h, and then was heated to using trypan blue staining (Sigma‑Aldrich; Merck KGaA) to 70˚C for10 min to produce cDNA. Subsequently, qPCR was ensure all of the cells were lysed. performed to detect the mRNA expression levels of RACK1, CTNNBL1, Cullin 3, B‑cell lymphoma 2‑associated tran- Isobaric tags for relative and absolute quantitation (iTRAQ) scription factor 1 (BCLAF1), ribosomal protein S6 (RPS6), analysis. TCL was prepared from Lewis lung cancer cells superoxide dismutase 1 (SOD1), high mobility group box or mouse type II alveolar epithelial cell using the above 1 (HMGB1), inhibitor of growth family member 1 (ING1), method. Protein concentration of TCL was determined ERCC excision repair 3, TFIIH core complex helicase subunit using a bicinchoninic acid (BCA) assay using bovine serum (ERCC3) and GAPDH in mouse Lewis lung cancer cell TCL albumin as standard (BCA Assay kit; Beyotime Institute of using a SuperReal PreMix Plus kit with SYBR Green (Tiangen Biotechnology, Shanghai, China). Subsequently, 100 µg TCL Biotech Co. Ltd.). Thermocycling conditions were 30 sec at protein was digested with trypsin (Promega Corporation, 95˚C, 2 step PCR at 95˚C for 0.5 sec and at 60˚C for 30 sec, Madison, WI, USA) overnight at 37˚C. Digested samples were for 40 cycles. Following dissociation was 1 cycle at 95˚C for labeled using the 8‑plex iTRAQ kit (Applied Biosystems; 15 sec, at 60˚C for 30 sec and at 95˚C for 15 sec successively.
Recommended publications
  • Coupling of Spliceosome Complexity to Intron Diversity
    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.19.436190; this version posted March 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Coupling of spliceosome complexity to intron diversity Jade Sales-Lee1, Daniela S. Perry1, Bradley A. Bowser2, Jolene K. Diedrich3, Beiduo Rao1, Irene Beusch1, John R. Yates III3, Scott W. Roy4,6, and Hiten D. Madhani1,6,7 1Dept. of Biochemistry and Biophysics University of California – San Francisco San Francisco, CA 94158 2Dept. of Molecular and Cellular Biology University of California - Merced Merced, CA 95343 3Department of Molecular Medicine The Scripps Research Institute, La Jolla, CA 92037 4Dept. of Biology San Francisco State University San Francisco, CA 94132 5Chan-Zuckerberg Biohub San Francisco, CA 94158 6Corresponding authors: [email protected], [email protected] 7Lead Contact 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.03.19.436190; this version posted March 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. SUMMARY We determined that over 40 spliceosomal proteins are conserved between many fungal species and humans but were lost during the evolution of S. cerevisiae, an intron-poor yeast with unusually rigid splicing signals. We analyzed null mutations in a subset of these factors, most of which had not been investigated previously, in the intron-rich yeast Cryptococcus neoformans.
    [Show full text]
  • GLUTATHIONE TRANSFERASE N STRUCTURE and GENE REGULATION
    GLUTATHIONE TRANSFERASE n STRUCTURE AND GENE REGULATION By Chu-Lin Xia This report is in part-fulfillment of the requirements for the degree of doctor of philosophy in the University of London University College, University of London January 1992 ProQuest Number: 10609162 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 10609162 Published by ProQuest LLC(2017). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 ABSTRACT In the early stage of this research, amino acid residues that are essential for the activity of human pi class glutathione transferase (GST n) were identified using chemical modification with group-specific reagents. Protection from inactivation by substrates, substrate analogues and inhibitors was used as the criterion for active site specificity. The results suggested the apparent involvement of one cysteine (Cys), one lysine (Lys), one arginine (Arg), one histidine (His) or tyrosine (Tyr) or both, one aspartate (Asp) or glutamate (Glu) and tryptophan (Trp) residues in the glutathione binding site (G-site) of GSTtc. It was concluded that without the knowledge of the three-dimensional structure of GST 7i, further work in this area would not be profitable and therefore, attention was turned to the regulation of GST n gene expression.
    [Show full text]
  • Essential Genes and Their Role in Autism Spectrum Disorder
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2017 Essential Genes And Their Role In Autism Spectrum Disorder Xiao Ji University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Bioinformatics Commons, and the Genetics Commons Recommended Citation Ji, Xiao, "Essential Genes And Their Role In Autism Spectrum Disorder" (2017). Publicly Accessible Penn Dissertations. 2369. https://repository.upenn.edu/edissertations/2369 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2369 For more information, please contact [email protected]. Essential Genes And Their Role In Autism Spectrum Disorder Abstract Essential genes (EGs) play central roles in fundamental cellular processes and are required for the survival of an organism. EGs are enriched for human disease genes and are under strong purifying selection. This intolerance to deleterious mutations, commonly observed haploinsufficiency and the importance of EGs in pre- and postnatal development suggests a possible cumulative effect of deleterious variants in EGs on complex neurodevelopmental disorders. Autism spectrum disorder (ASD) is a heterogeneous, highly heritable neurodevelopmental syndrome characterized by impaired social interaction, communication and repetitive behavior. More and more genetic evidence points to a polygenic model of ASD and it is estimated that hundreds of genes contribute to ASD. The central question addressed in this dissertation is whether genes with a strong effect on survival and fitness (i.e. EGs) play a specific oler in ASD risk. I compiled a comprehensive catalog of 3,915 mammalian EGs by combining human orthologs of lethal genes in knockout mice and genes responsible for cell-based essentiality.
    [Show full text]
  • CTNNBL1 (NM 030877) Human Recombinant Protein Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TP324836 CTNNBL1 (NM_030877) Human Recombinant Protein Product data: Product Type: Recombinant Proteins Description: Recombinant protein of human catenin, beta like 1 (CTNNBL1) Species: Human Expression Host: HEK293T Tag: C-Myc/DDK Predicted MW: 65 kDa Concentration: >50 ug/mL as determined by microplate BCA method Purity: > 80% as determined by SDS-PAGE and Coomassie blue staining Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol Preparation: Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. Storage: Store at -80°C. Stability: Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. RefSeq: NP_110517 Locus ID: 56259 UniProt ID: Q8WYA6 RefSeq Size: 1897 Cytogenetics: 20q11.23 RefSeq ORF: 1689 Synonyms: C20orf33; dJ633O20.1; NAP; P14L; PP8304 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 CTNNBL1 (NM_030877) Human Recombinant Protein – TP324836 Summary: The protein encoded by this gene is a component of the pre-mRNA-processing factor 19-cell division cycle 5-like (PRP19-CDC5L) protein complex, which activates pre-mRNA splicing and is an integral part of the spliceosome. The encoded protein is also a nuclear localization sequence binding protein, and binds to activation-induced deaminase and is important for antibody diversification.
    [Show full text]
  • Original Communication Genomic and Expression Array Profiling of Chromosome 20Q Amplicon in Human Colon Cancer Cells
    128 Original Communication Genomic and expression array profiling of chromosome 20q amplicon in human colon cancer cells Jennifer l Carter, Li Jin,1 Subrata Sen University of Texas - M. D. Anderson Cancer Center, 1PD, University of Cincinnati sion and metastasis.[1,2] Characterization of genomic BACKGROUND: Gain of the q arm of chromosome 20 in human colorectal cancer has been associated with poorer rearrangements is, therefore, a major area of investiga- survival time and has been reported to increase in frequency tion being pursued by the cancer research community. from adenomas to metastasis. The increasing frequency of chromosome 20q amplification during colorectal cancer Amplification of genomic DNA is one such form of rear- progression and the presence of this amplification in carci- rangement that leads to an increase in the copy num- nomas of other tissue origin has lead us to hypothesize ber of specific genes frequently detected in a variety of that 20q11-13 harbors one or more genes which, when over expressed promote tumor invasion and metastasis. human cancer cell types. Our laboratory has been in- AIMS: Generate genomic and expression profiles of the terested in characterizing amplified genomic regions in 20q amplicon in human cancer cell lines in order to identify genes with increased copy number and expression. cancer cells based on the hypothesis that these seg- MATERIALS AND METHODS: Utilizing genomic sequenc- ments harbor critical genes associated with initiation and/ ing clones and amplification mapping data from our lab or progression of cancer. Gain of chromosome 20q in and other previous studies, BAC/ PAC tiling paths span- ning the 20q amplicon and genomic microarrays were gen- human colorectal cancer has been associated with erated.
    [Show full text]
  • Expressed Gene Fusions As Frequent Drivers of Poor Outcomes in Hormone Receptor–Positive Breast Cancer
    Published OnlineFirst December 14, 2017; DOI: 10.1158/2159-8290.CD-17-0535 RESEARCH ARTICLE Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor–Positive Breast Cancer Karina J. Matissek1,2, Maristela L. Onozato3, Sheng Sun1,2, Zongli Zheng2,3,4, Andrew Schultz1, Jesse Lee3, Kristofer Patel1, Piiha-Lotta Jerevall2,3, Srinivas Vinod Saladi1,2, Allison Macleay3, Mehrad Tavallai1,2, Tanja Badovinac-Crnjevic5, Carlos Barrios6, Nuran Beşe7, Arlene Chan8, Yanin Chavarri-Guerra9, Marcio Debiasi6, Elif Demirdögen10, Ünal Egeli10, Sahsuvar Gökgöz10, Henry Gomez11, Pedro Liedke6, Ismet Tasdelen10, Sahsine Tolunay10, Gustavo Werutsky6, Jessica St. Louis1, Nora Horick12, Dianne M. Finkelstein2,12, Long Phi Le2,3, Aditya Bardia1,2, Paul E. Goss1,2, Dennis C. Sgroi2,3, A. John Iafrate2,3, and Leif W. Ellisen1,2 ABSTRACT We sought to uncover genetic drivers of hormone receptor–positive (HR+) breast cancer, using a targeted next-generation sequencing approach for detecting expressed gene rearrangements without prior knowledge of the fusion partners. We identified inter- genic fusions involving driver genes, including PIK3CA, AKT3, RAF1, and ESR1, in 14% (24/173) of unselected patients with advanced HR+ breast cancer. FISH confirmed the corresponding chromo- somal rearrangements in both primary and metastatic tumors. Expression of novel kinase fusions in nontransformed cells deregulates phosphoprotein signaling, cell proliferation, and survival in three- dimensional culture, whereas expression in HR+ breast cancer models modulates estrogen-dependent growth and confers hormonal therapy resistance in vitro and in vivo. Strikingly, shorter overall survival was observed in patients with rearrangement-positive versus rearrangement-negative tumors. Cor- respondingly, fusions were uncommon (<5%) among 300 patients presenting with primary HR+ breast cancer.
    [Show full text]
  • Identification of Shared Genetic Susceptibility Locus for Coronary Artery Disease, Type 2 Diabetes and Obesity: a Meta-Analysis of Genome-Wide Studies
    Wu et al. Cardiovascular Diabetology 2012, 11:68 CARDIO http://www.cardiab.com/content/11/1/68 VASCULAR DIABETOLOGY REVIEW Open Access Identification of shared genetic susceptibility locus for coronary artery disease, type 2 diabetes and obesity: a meta-analysis of genome-wide studies Chaoneng Wu1,2†, Yunguo Gong1,2†, Jie Yuan1,2, Hui Gong1,2, Yunzeng Zou1,2,3* and Junbo Ge1,2,3* Abstract Type 2 diabetes (2DM), obesity, and coronary artery disease (CAD) are frequently coexisted being as key components of metabolic syndrome. Whether there is shared genetic background underlying these diseases remained unclear. We performed a meta-analysis of 35 genome screens for 2DM, 36 for obesity or body mass index (BMI)-defined obesity, and 21 for CAD using genome search meta-analysis (GSMA), which combines linkage results to identify regions with only weak evidence and provide genetic interactions among different diseases. For each study, 120 genomic bins of approximately 30 cM were defined and ranked according to the best linkage evidence within each bin. For each disease, bin 6.2 achieved genomic significanct evidence, and bin 9.3, 10.5, 16.3 reached suggestive level for 2DM. Bin 11.2 and 16.3, and bin 10.5 and 9.3, reached suggestive evidence for obesity and CAD respectively. In pooled all three diseases, bin 9.3 and 6.5 reached genomic significant and suggestive evidence respectively, being relatively much weaker for 2DM/CAD or 2DM/obesity or CAD/obesity. Further, genomewide significant evidence was observed of bin 16.3 and 4.5 for 2DM/obesity, which is decreased when CAD was added.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 5,869,438 Svendsen Et Al
    USOO5869438A United States Patent (19) 11 Patent Number: 5,869,438 Svendsen et al. (45) Date of Patent: Feb. 9, 1999 54) LIPASE WARIANTS 52 U.S. Cl. ......................... 510/226; 435/198; 435/69.1; 435/252.3; 435/320.1; 435/196; 536/23.2; 75 Inventors: Allan Svendsen, Birkerød; Shamkant 536/23.7; 530/350; 510/392; 510/305 Anant Patkar, Lyngby; Erik Gormsen, 58 Field of Search ..................................... 435/198, 196, Virum; Jens Sigurd Okkels; Marianne 435/187-188, 69.1, 252.3, 320.1, 71.1; Thellersen, both of Frederiksberg, all of 424/94.1; 536/22.2, 23.7; 510/305, 226, Denmark 392 73 Assignee: Novo Nordisk A/S, Bagsvaerd, 56) References Cited Denmark FOREIGN PATENT DOCUMENTS 21 Appl. No.: 479,275 O305 216 A1 3/1989 European Pat. Off.. O 407 225A1 1/1991 European Pat. Off.. 22 Filed: Jun. 7, 1995 WO95/09909 4/1995 WIPO. Related U.S. Application Data Primary Examiner Robert A. Wax ASSistant Examiner Tekchand Saidha 63 Continuation-in-part of PCT/DK94/00162, Apr. 22, 1994, which is a continuation-in-part of PCT/DK95/00079, Feb. Attorney, Agent, or Firm-Steve T. Belson; Elias J. 27, 1995, which is a continuation-in-part of Ser. No. 434, Lambiris 904, May 1, 1995, abandoned, which is a continuation of Ser. No. 977,429, which is a continuation of PCT/DK91/ 57 ABSTRACT 00271, Sep. 13, 1991, abandoned. The present invention relates to lipase variants which exhibit 30 Foreign Application Priority Data improved properties, detergent compositions comprising Said lipase variants, DNA constructs coding for Said lipase Sep.
    [Show full text]
  • The Role of the Rho Gtpases in Neuronal Development
    Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW The role of the Rho GTPases in neuronal development Eve-Ellen Govek,1,2, Sarah E. Newey,1 and Linda Van Aelst1,2,3 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 11724, USA; 2Molecular and Cellular Biology Program, State University of New York at Stony Brook, Stony Brook, New York, 11794, USA Our brain serves as a center for cognitive function and and an inactive GDP-bound state. Their activity is de- neurons within the brain relay and store information termined by the ratio of GTP to GDP in the cell and can about our surroundings and experiences. Modulation of be influenced by a number of different regulatory mol- this complex neuronal circuitry allows us to process that ecules. Guanine nucleotide exchange factors (GEFs) ac- information and respond appropriately. Proper develop- tivate GTPases by enhancing the exchange of bound ment of neurons is therefore vital to the mental health of GDP for GTP (Schmidt and Hall 2002); GTPase activat- an individual, and perturbations in their signaling or ing proteins (GAPs) act as negative regulators of GTPases morphology are likely to result in cognitive impairment. by enhancing the intrinsic rate of GTP hydrolysis of a The development of a neuron requires a series of steps GTPase (Bernards 2003; Bernards and Settleman 2004); that begins with migration from its birth place and ini- and guanine nucleotide dissociation inhibitors (GDIs) tiation of process outgrowth, and ultimately leads to dif- prevent exchange of GDP for GTP and also inhibit the ferentiation and the formation of connections that allow intrinsic GTPase activity of GTP-bound GTPases (Zalc- it to communicate with appropriate targets.
    [Show full text]
  • Expression Analysis of Genes Located Within the Common Deleted Region
    Leukemia Research 84 (2019) 106175 Contents lists available at ScienceDirect Leukemia Research journal homepage: www.elsevier.com/locate/leukres Research paper Expression analysis of genes located within the common deleted region of del(20q) in patients with myelodysplastic syndromes T ⁎ Masayuki Shiseki , Mayuko Ishii, Michiko Okada, Mari Ohwashi, Yan-Hua Wang, Satoko Osanai, Kentaro Yoshinaga, Naoki Mori, Toshiko Motoji, Junji Tanaka Department of Hematology, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan ARTICLE INFO ABSTRACT Keywords: Deletion of the long arm of chromosome 20 (del(20q)) is observed in 5–10% of patients with myelodysplastic Deletion 20q syndromes (MDS). We examined the expression of 28 genes within the common deleted region (CDR) of del Common deleted region (20q), which we previously determined by a CGH array using clinical samples, in 48 MDS patients with (n = 28) Myelodysplastic syndromes or without (n = 20) chromosome 20 abnormalities and control subjects (n = 10). The expression level of 8 of 28 genes was significantly reduced in MDS patients with chromosome 20 abnormalities compared to that of control subjects. In addition, the expression of BCAS4, ADA, and YWHAB genes was significantly reduced in MDS pa- tients without chromosome 20 abnormalities, which suggests that these three genes were commonly involved in the molecular pathogenesis of MDS. To evaluate the clinical significance, we analyzed the impact of the ex- pression level of each gene on overall survival (OS). According to the Cox proportional hazard model, multi- variate analysis indicated that reduced BCAS4 expression was associated with inferior OS, but the difference was not significant (HR, 3.77; 95% CI, 0.995-17.17; P = 0.0509).
    [Show full text]
  • A Systematic, Label-Free Method for Identifying RNA-Associated Proteins in Vivo Provides Insights Into Vertebrate Ciliary Beatin
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.26.966754; this version posted March 2, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 A systematic, label-free method for identifying RNA- associated proteins in vivo provides insights into vertebrate ciliary beating Kevin Drew*, Chanjae Lee*, Rachael M. Cox, Vy Dang, Caitlin C. Devitt, Ophelia Papoulas, Ryan L. Huizar, Edward M. Marcotte** and John B. Wallingford** Dept. of Molecular Biosciences, Center for Systems and Synthetic Biology, University of Texas, Austin, TX 78712 *These authors contributed equally **To whom correspondence should be addressed: John Wallingford Patterson Labs 2401 Speedway Austin, Texas 78712 [email protected] 512-232-2784 Edward Marcotte 2500 Speedway, MBB 3.148BA Austin, Texas 78712 [email protected] 512-471-5435 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.26.966754; this version posted March 2, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 2 Abstract: Cell-type specific RNA-associated proteins (RAPs) are essential for development and homeostasis in animals. Despite a massive recent effort to systematically identify RAPs, we currently have few comprehensive rosters of cell-type specific RAPs in vertebrate tissues. Here, we demonstrate the feasibility of determining the RNA-interacting proteome of a defined vertebrate embryonic tissue using DIF-FRAC, a systematic and universal (i.e., label-free) method.
    [Show full text]
  • Newly Identified Gon4l/Udu-Interacting Proteins
    www.nature.com/scientificreports OPEN Newly identifed Gon4l/ Udu‑interacting proteins implicate novel functions Su‑Mei Tsai1, Kuo‑Chang Chu1 & Yun‑Jin Jiang1,2,3,4,5* Mutations of the Gon4l/udu gene in diferent organisms give rise to diverse phenotypes. Although the efects of Gon4l/Udu in transcriptional regulation have been demonstrated, they cannot solely explain the observed characteristics among species. To further understand the function of Gon4l/Udu, we used yeast two‑hybrid (Y2H) screening to identify interacting proteins in zebrafsh and mouse systems, confrmed the interactions by co‑immunoprecipitation assay, and found four novel Gon4l‑interacting proteins: BRCA1 associated protein‑1 (Bap1), DNA methyltransferase 1 (Dnmt1), Tho complex 1 (Thoc1, also known as Tho1 or HPR1), and Cryptochrome circadian regulator 3a (Cry3a). Furthermore, all known Gon4l/Udu‑interacting proteins—as found in this study, in previous reports, and in online resources—were investigated by Phenotype Enrichment Analysis. The most enriched phenotypes identifed include increased embryonic tissue cell apoptosis, embryonic lethality, increased T cell derived lymphoma incidence, decreased cell proliferation, chromosome instability, and abnormal dopamine level, characteristics that largely resemble those observed in reported Gon4l/udu mutant animals. Similar to the expression pattern of udu, those of bap1, dnmt1, thoc1, and cry3a are also found in the brain region and other tissues. Thus, these fndings indicate novel mechanisms of Gon4l/ Udu in regulating CpG methylation, histone expression/modifcation, DNA repair/genomic stability, and RNA binding/processing/export. Gon4l is a nuclear protein conserved among species. Animal models from invertebrates to vertebrates have shown that the protein Gon4-like (Gon4l) is essential for regulating cell proliferation and diferentiation.
    [Show full text]